STOCK TITAN

Seritage Growth Properties posts $2.74M Q3 profit

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
8-K

Rhea-AI Filing Summary

Seritage Growth Properties (SRG) reported third-quarter 2026 results: revenue was $1.635 million, compared with $4.785 million a year earlier, while net income attributable to common shareholders was $2.735 million, versus a $13.647 million loss. For the nine months ended September 30, 2026, revenue was $5.559 million versus $14.037 million, and the common-shareholder net loss was $36.161 million versus $66.805 million.

During the quarter, SRG generated $3.0 million in gross proceeds from selling one vacant, non-income-producing asset and received an $8.9 million distribution from an unconsolidated entity following a partial sale of underlying property. A separate option agreement covers a Dallas vacant, non-income-producing premier asset, with anticipated gross proceeds of $50.8 million before applicable credits and costs. The sale is subject to customary closing conditions, and there is no assurance the buyer will exercise the option.

Cash was $45.4 million as of September 30, including $32.7 million of restricted cash; SRG also reported $10.0 million available under its revolving loan facility. New loan proceeds and cash repaid the prior $50.0 million term-loan balance. The company said challenging market conditions could continue to adversely affect Plan of Sale proceeds and distributions.

1 point · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

0 major · 1 point

How the balance works

Positive

  • Moderate pointNine-month common-shareholder net loss narrowed to $36.161 million from $66.805 million.

Negative

  • Moderate pointNine-month revenue fell to $5.559 million from $14.037 million.

Filing Explained

As of November 12, Seritage reported $41.4 million in cash, including $32.7 million restricted, plus $10.0 million of revolver availability.

The release reports a board-declared $0.43750-per-share Series A preferred dividend payable January 15, 2027, setting a scheduled distribution to preferred holders.

Seritage’s release says a purported shareholder’s securities suit names the company, its CEO and CFO, and alleges false or misleading disclosures about impairment controls and property values. It says three derivative suits targeting current or former officers and trustees, with the company named as a nominal defendant, are stayed pending resolution of an anticipated motion to dismiss in the securities case. The complaints seek compensatory damages in unspecified amounts.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Total revenue, three months $1.635 million Three months ended September 30, 2026; $4.785 million for the same period in 2025.
Net income attributable to common shareholders, three months $2.735 million Three months ended September 30, 2026; a $13.647 million loss for the same period in 2025.
Total revenue, nine months $5.559 million Nine months ended September 30, 2026; $14.037 million for the same period in 2025.
Net loss attributable to common shareholders, nine months $36.161 million loss Nine months ended September 30, 2026; a $66.805 million loss for the same period in 2025.
Impairment of real estate assets $15.183 million Nine months ended September 30, 2026.
Cash on hand $45.4 million, including $32.7 million of restricted cash As of September 30, 2026.
Revolving loan facility availability $10.0 million As of September 30, 2026.
Anticipated gross proceeds from Dallas asset sale $50.8 million Before applicable credits and costs; sale is subject to customary closing conditions and an option agreement.
option purchase and sale agreement technical
"entered into an option purchase and sale agreement"
A legal contract that sets the terms for an option tied to the future purchase or sale of an asset, spelling out who can buy or sell, the price, time window, and any conditions or closing steps. Think of it like a reservation or ticket that gives one party the right (but not always the obligation) to complete a deal later; investors care because such agreements can change future ownership, cash flows, risk exposure, and how a company’s value or share count might evolve.
other-than-temporary impairment loss financial
"recorded an other-than-temporary impairment loss of $5.2 million"
revolving loan facility financial
"availability under its revolving loan facility"
A revolving loan facility is a flexible credit line a company can draw from, repay, and draw again as needed, similar to a business-sized credit card. It matters to investors because it provides short-term cash for operations, acquisitions, or unexpected expenses without issuing new shares, and its size, cost, and terms signal a company’s liquidity, borrowing capacity and financial resilience under stress.
restricted cash financial
"including $32.7 million of restricted cash"
Cash that a company holds but cannot use for day-to-day operations because it is set aside for a specific purpose—such as meeting loan covenants, serving as collateral, funding an escrow, or complying with regulations. Like money in a locked savings account earmarked for a bill, restricted cash reduces the cash available to run the business and pay dividends or debts, so investors treat it differently when assessing a company’s true short-term financial strength.
gross leasable area technical
"approximately 0.7 million square feet of gross leasable area"
Total floor area in a commercial property that can be leased to tenants, measured in square feet or meters and excluding shared spaces like corridors, lobbies, service rooms and structural elements. Investors use it as a simple measure of a building’s income-generating capacity—like counting the number of rentable storefronts in a mall—to estimate potential rental revenue, compare properties, evaluate occupancy, and help determine property value and returns.
unconsolidated entities financial
"investment in unconsolidated entities"
Unconsolidated entities are companies, joint ventures, or investments that a reporting company has a meaningful stake in but does not control, so their full assets and liabilities are not combined into the reporting company’s financial statements. They are usually shown as investments (often under the equity method) rather than consolidated line-by-line. For investors, these holdings can affect future earnings, cash flows and exposure to risk even though they don’t appear on the parent company’s balance sheet in the same way—similar to owning a share of a business instead of running it outright.
Total revenue, three months $1.635 million Down from $4.785 million in the same period of 2025.
Net income attributable to common shareholders, three months $2.735 million Compared with a $13.647 million loss in the same period of 2025.
Total revenue, nine months $5.559 million Down from $14.037 million in the same period of 2025.
Net loss attributable to common shareholders, nine months $36.161 million loss Narrowed from a $66.805 million loss in the same period of 2025.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What were SRG's third-quarter 2026 revenue and earnings?

SRG reported $1.635 million in revenue and $2.735 million in net income attributable to common shareholders. In the third quarter of 2025, revenue was $4.785 million and net income attributable to common shareholders was a $13.647 million loss.

How much cash and revolving credit did SRG have available?

As of September 30, 2026, SRG had $45.4 million in cash on hand, including $32.7 million of restricted cash, and $10.0 million available under its revolving loan facility. As of November 12, 2026, cash on hand was $41.4 million, including $32.7 million of restricted cash, with $10.0 million of revolver availability.

What debt facilities did SRG enter into in July 2026?

On July 24, 2026, SRG entered into a $15.0 million term loan facility and a $25.0 million revolving loan facility. It drew $15.0 million under the revolver at closing, then used proceeds from the new loans together with cash on hand to repay the prior term loan's $50.0 million outstanding balance.

What are the terms of SRG's proposed Dallas property sale?

An option purchase and sale agreement covers a vacant, non-income-producing premier asset in Dallas, Texas, for anticipated gross proceeds of $50.8 million before applicable credits and costs. The sale is subject to customary closing conditions and is cross-conditioned and cross-defaulted with an agreement for a neighboring parcel; there is no assurance the buyer will exercise the option.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false00016280630001628063us-gaap:CommonStockMember2026-11-132026-11-130001628063srg:Seven00SeriesACumulativeRedeemablePreferredSharesOfBeneficialInterestParValue001PerShareMember2026-11-132026-11-1300016280632026-11-132026-11-13

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): November 13, 2026

 

 

SERITAGE GROWTH PROPERTIES

(Exact name of Registrant as Specified in Its Charter)

 

 

Maryland

001-37420

38-3976287

(State or Other Jurisdiction
of Incorporation)

(Commission File Number)

(IRS Employer
Identification No.)

 

 

 

 

 

500 Fifth Avenue, Suite 1530

 

New York, New York

 

10110

(Address of Principal Executive Offices)

 

(Zip Code)

 

Registrant’s Telephone Number, Including Area Code: 212 355-7800

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:


Title of each class

 

Trading
Symbol(s)

 


Name of each exchange on which registered

Class A common shares of beneficial interest, par value $0.01 per share

 

SRG

 

New York Stock Exchange

7.00% Series A cumulative redeemable preferred shares of beneficial interest, par value $0.01 per share

 

SRG-PA

 

New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 


 

Item 2.02 Results of Operations and Financial Condition.

On November 13 2026, the Company issued a press release regarding its financial results for the three and nine months ended September 30, 2026. A copy of the press release is furnished as Exhibit 99.1 to this report.

In accordance with General Instruction B.2 of Form 8-K, the information in this Current Report on Form 8-K, including Exhibits 99.1, shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, and shall not be incorporated by reference into any registration statement or other document filed under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press release dated November 13, 2026

 

 

 

104

 

Cover Page Interactive Data File (embedded within Inline XBRL document)

 

 


 

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

SERITAGE GROWTH PROPERTIES

 

By:

 

/s/ Matthew Fernand

 

 

Matthew Fernand

 

 

Chief Legal Officer and Corporate Secretary

 

Date: November 13 2026

 


 

Exhibit 99.1

 

img42621_0.jpg

 

 

Seritage Growth Properties Reports Third Quarter 2026 Operating Results

 

New York – November 13 2026, Seritage Growth Properties (NYSE: SRG) (the “Company”), a national owner and developer of retail, residential and mixed-use properties today reported financial and operating results for the three and nine months ended September 30, 2026.

 

“Although we have no new transactions under contract, we continue to work on both individual asset sales and potential strategic options for the portfolio and the Company” said Adam Metz, CEO & President.

 

Q3 Sale Highlights:

 

•
Generated gross proceeds of $3.0 million from the sale of one vacant/non-income producing asset and received a distribution of $8.9 million from an unconsolidated entity as a result of the sale of a portion of the underlying property.
•
As previously disclosed, the Company has entered into an option purchase and sale agreement (the “PSA”) to sell one vacant non-income producing premier asset in Dallas, Texas for anticipated gross proceeds of $50.8 million before applicable credits and costs. The sale is subject to customary closing conditions and is also cross-conditioned and cross-defaulted with an option purchase and sale agreement between the buyer and unaffiliated owners of a neighboring parcel. The buyer made an initial option payment of $169,200, then (i) commencing on July 1, 2026, and each month thereafter that the PSA remains in effect through December 1, 2026, the Company shall receive an option payment equal to $126,900 and (ii) commencing on January 1, 2027, and each month thereafter that the PSA remains in effect through January 1, 2028, the Company shall receive an option payment equal to $274,950. All option payments are incremental to the purchase price and are non-refundable except as otherwise provided for in the PSA. There can be no assurances that the buyer will exercise the option to purchase the property. The Company has received $0.6 million of option payments through September 30, 2026.

Financial Highlights:

For the three and nine months ended September 30, 2026:

•
As of September 30, 2026, the Company had cash on hand of $45.4 million, including $32.7 million of restricted cash, as well as $10.0 million of availability under its revolving loan facility discussed below. As of November 12, 2026, the Company had cash on hand of $41.4 million, including $32.7 million of restricted cash, and $10.0 million of availability under its revolving loan facility.
•
During the three and nine months ended September 30, 2026, the Company invested $1.9 million and $2.8 million, respectively, in its consolidated properties and $0.3 million and $2.8 million, respectively, in its unconsolidated properties.
•
During the three and nine months ended September 30, 2026, the Company received distributions of $10.4 million and $19.2 million, respectively, from its unconsolidated properties.
•
The Company did not recognize any impairment charges on its consolidated properties for the three months ended September 30, 2026. The Company recognized an impairment charge of $15.2 million on one of its consolidated properties during the nine months ended September 30, 2026.
•
During the three months ended September 30, 2026, the Company did not record any other-than-temporary impairment losses on its unconsolidated entities. The Company recorded an other-than-temporary impairment loss of $5.2 million on one of its unconsolidated entities during the nine months ended September 30, 2026.
•
The Company reported net income attributable to common shareholders of $2.7 million, or $0.05 per share, for the three months ended September 30, 2026, and a net loss attributable to common shareholders of ($36.2) million, or ($0.64) per share, for the nine months ended September 30, 2026.
•
On July 24, 2026, the Company entered into a new $15.0 million term loan facility and a $25.0 million revolving loan facility. At closing, the Company drew $15.0 million under the revolving loan facility, leaving $10.0 million available for future borrowings.

1


 

The Company used a combination of the proceeds from the closing of the new loans together with cash on hand to fully repay the $50.0 million outstanding balance on its prior term loan facility.

Portfolio

The table below represents a summary of the Company’s properties as of September 30, 2026 (in thousands except number of leases and acreage data):

 

Planned Usage

 

Total

 

Built SF / Acreage (1)

 

Leased SF (1)(2)

 

 

% Leased

 

Avg. Acreage / Site

 

Consolidated

 

 

 

 

 

 

 

 

 

 

 

 

Multi-Tenant Retail

 

1

 

 209 sf / 14 acres

 

 

175

 

 

83.6%

 

 

14.1

 

Premier

 

2

 

 8 sf / 38 acres

 

 

-

 

 

0.0%

 

 

18.6

 

Unconsolidated

 

 

 

 

 

 

 

 

 

 

 

 

Other Joint Ventures

 

2

 

 93 sf / 28 acres

 

 

5

 

 

5.1%

 

 

14.2

 

Premier

 

3

 

 158 sf / 53 acres

 

 

106

 

 

67.4%

 

 

17.8

 

 

(1) Square footage is presented at the Company’s proportional share.

(2) Based on signed leases at September 30, 2026.

 

Financial Summary

The table below provides a summary of the Company’s financial results for the three and nine months ended September 30, 2026:

 

 

 

Three Months Ended

 

 

Nine Months Ended

 

 

 

September 30, 2026

 

 

September 30, 2025

 

 

September 30, 2026

 

 

September 30, 2025

 

Net income (loss) attributable to Seritage common shareholders

 

$

2,735

 

 

$

(13,647

)

 

$

(36,161

)

 

$

(66,805

)

Net income (loss) per share attributable to Seritage common shareholders

 

 

0.05

 

 

 

(0.24

)

 

 

(0.64

)

 

 

(1.19

)

 

As of September 30, 2026, the Company had cash on hand of $45.4 million, including $32.7 million of restricted cash. On July 24, 2026, the Company entered into a new $15.0 million term loan facility and a $25.0 million revolving loan facility. At closing, the Company drew $15.0 million under the revolving loan facility, leaving $10.0 million available for future borrowings. The Company used the proceeds from the closing of the new term loan facility and the initial draw under the revolving loan facility together with cash on hand to fully repay the $50.0 million outstanding balance on its prior term loan facility. The Company expects to use existing cash on hand and its availability under the revolving loan facility to pay for its financing obligations and fund its operations and development activity. For more information on our liquidity position, including our going concern analysis, please see the notes to the consolidated financial statements included in Part I, Item 1 and in the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” each in our Quarterly Report on Form 10-Q.

 

Litigation Matters

 

On July 1, 2024, a purported shareholder of the Company filed a class action lawsuit in the U.S. District Court for the Southern District of New York, captioned Zhengxu He, Trustee of the He & Fang 2005 Revocable Living Trust v. Seritage Growth Properties, Case No. 1:24:CV:05007, alleging that the Company, the Company’s Chief Executive Officer, and the Company’s Chief Financial Officer violated the federal securities laws (the “Securities Action”). The complaint seeks to bring a class action on behalf of all persons and entities that purchased or otherwise acquired Company securities between July 7, 2022 and May 10, 2024. The complaint alleges that the defendants violated federal securities laws by issuing false, misleading, and/or omissive disclosures concerning the Company’s alleged lack of effective internal controls regarding the identification and review of impairment indicators for investments in real estate and the Company’s value and projected gross proceeds of certain real estate assets. The complaint seeks compensatory damages in an unspecified amount to be proven at trial, an award of reasonable costs and expenses to the plaintiff and class counsel, and such other and further relief as the court may deem just and proper. On or around January 15, 2025, another purported shareholder of the Company filed a derivative lawsuit in the U.S. District Court for the District of Maryland, captioned Paul Sidhu v. Seritage Growth Properties, Case No. 1:25-cv-00152 (the “Sidhu Derivative Action”). On or around January 20, 2025, another purported shareholder of the Company filed a derivative lawsuit in the U.S. District Court for the District of Maryland, captioned James Wallen v. Seritage Growth Properties, Case No. 1:25-cv-00190 (the “Wallen Derivative Action”). On or around May 8, 2025, another purported shareholder of the Company

2


 

filed a derivative lawsuit in the U.S. District Court for the Southern District of New York, captioned Derrick Cheroti v. Seritage Growth Properties, Case No. 1:25-vc-00152 (the “Cheroti Derivative Action”). The derivative actions allege the same or similar claimed acts and omissions underlying the Securities Action, assert breach of fiduciary duty and other claims against the Company’s Chief Executive Officer, the Company’s Chief Financial Officer, and current and former members of the Company’s Board of Trustees, and name the Company as a nominal defendant. The complaint in each of the derivative actions seeks compensatory damages in an unspecified amount to be proven at trial, an order directing the Company and the individual defendants to reform and improve the Company’s corporate governance and internal procedures, restitution from the individual defendants, an award of costs and expenses to the plaintiff and reasonable attorneys’ and experts’ fees, costs, and expenses, and such other and further relief as the court may deem just and proper. The complaint in the Cheroti Derivative Action also seeks an award of punitive damages, an order directing the individual defendants to account for all damages caused by them and all profits and special benefits and unjust enrichment obtained, and the imposition of a constructive trust. On September 2, 2025, the court in the Cheroti Derivative Action stayed the Cheroti Derivative Action until resolution of the anticipated motion to dismiss in the Securities Action. On November 5, 2025, the court in the District of Maryland proceedings consolidated the Sidhu Derivative Action and the Wallen Derivative Action (the “Consolidated Derivative Action”) and appointed lead counsel. On November 12, 2025, the court in the Consolidated Derivative Action stayed the Consolidated Derivative Action until resolution of the anticipated motion to dismiss in the Securities Action. The Company intends to vigorously defend itself against the allegations in these lawsuits.

Dividends

 

The Company's Board of Trustees has declared the following dividends on the preferred shares during 2026:

 

 

 

 

 

 

 

Series A

 

Declaration Date

 

Record Date

 

Payment Date

 

Preferred Share

 

2026

 

2026

 

 

 

 

 

October 27

 

December 31

 

January 15, 2027

 

$

0.43750

 

July 28

 

September 30

 

October 15, 2026

 

 

0.43750

 

April 20

 

June 30

 

July 15, 2026

 

 

0.43750

 

February 25

 

March 31

 

April 15, 2026

 

 

0.43750

 

Strategic Review

At the 2022 Annual Meeting of Shareholders on October 24, 2022, Seritage shareholders approved the Company’s Plan of Sale. The strategic review process remains ongoing as the Company executes the Plan of Sale, and the Company remains open-minded to pursuing value-maximizing alternatives, including a potential sale of the Company. There can be no assurance regarding the success of the process.

Market Update

The Company continues to face challenging market conditions, such as elevated interest rates and the availability of debt and equity capital, and it continues to assess other potential macroeconomic impacts including supply chain issues, international conflicts associated with tariffs, potential labor issues, and uncertainty caused by wars and the impacts thereof. Interest rates are currently higher than interest rates in 2022. Additionally, raising equity capital for land development deals remains challenging. These conditions could apply downward pricing pressures on our remaining assets. In making decisions regarding whether and when to transact on each of the Company’s remaining assets, the Company considers various factors including, but not limited to, the breadth of the buyer universe, macroeconomic conditions including the availability and cost of financing, as well as corporate, operating and other capital expenses required to carry the asset. If these challenging market conditions persist, then we expect that they will continue to adversely impact the Plan of Sale proceeds from our assets and the amounts and timing of distributions to shareholders.

Forward-Looking Statements

This document contains forward-looking statements within the meaning of the federal securities laws. Forward-looking statements relate to expectations, beliefs, projections, future plans and strategies, anticipated events or trends and similar expressions concerning matters that are not historical facts. In some cases, you can identify forward-looking statements by the use of forward-looking terminology such as “may,” “should,” “expects,” “intends,” “plans,” “pro forma,” “believes,” “estimates,” “predicts,” “potential,” “will,” “approximately,” or “anticipates” or the negative of these words and phrases or similar words or phrases that are predictions of or indicate future events or trends and that do not relate solely to historical matters. Forward-looking statements involve known and unknown risks, uncertainties, assumptions and contingencies, many of which are beyond the Company’s control, which may cause actual results to differ significantly from those expressed in any forward-looking statement. Factors that could cause or contribute to such differences include, but are not limited to: declines in retail, real estate and general economic conditions; risks relating to redevelopment activities and disposition of properties; the process and results of the Company’s review of strategic alternatives and our Plan of Sale; to contingencies to the commencement of rent under leases; the terms of the Company’s indebtedness and other legal

3


 

requirements to which the Company is subject; competition and related challenges in the real estate and retail industries and the ability of the Company’s top tenants to successfully operate their businesses; failure to achieve expected occupancy and/or rent levels within the projected time frame or at all; the impact of ongoing negative operating cash flow on the Company’s ability to fund operations and ongoing development; the Company’s ability to access or obtain sufficient sources of financing to fund the Company’s liquidity needs; environmental, health, safety and land use laws and regulations; and possible acts of war, terrorist activity or other acts of violence or cybersecurity incidents. For additional discussion of these and other applicable risks, assumptions and uncertainties, see the “Risk Factors” and forward-looking statement disclosure contained in the Company’s filings with the Securities and Exchange Commission, including the Company’s annual report on Form 10-K for the year ended December 31, 2025 and any subsequent Form 10-Qs. While the Company believes that its forecasts and assumptions are reasonable, the Company cautions that actual results may differ materially. The Company intends the forward-looking statements to speak only as of the time made and do not undertake to update or revise them as more information becomes available, except as required by law.

 

About Seritage Growth Properties

Prior to the adoption of the Company’s Plan of Sale, Seritage was principally engaged in the ownership, development, redevelopment, management, sale and leasing of diversified retail and mixed-use properties throughout the United States. As of September 30, 2026, the Company’s portfolio consisted of interests in eight properties comprised of approximately 0.7 million square feet of gross leasable area (“GLA”) or build-to-suit leased area and 133 acres of land. The portfolio encompasses three consolidated properties consisting of approximately 0.2 million square feet of GLA and 51 acres (such properties, the “Consolidated Properties”) and five unconsolidated entities consisting of approximately 0.5 million square feet of GLA and 82 acres (such properties, the “Unconsolidated Properties”).

 

Contact

Seritage Growth Properties

(212) 355-7800

IR@Seritage.com

4


 

Seritage Growth Properties

Consolidated Balance SheetS

(In thousands, except share and per share amounts)

(Unaudited)

 

 

 

September 30, 2026

 

 

December 31, 2025

 

ASSETS

 

 

 

 

 

 

Investment in real estate

 

 

 

 

 

 

Land

 

$

19,754

 

 

$

25,406

 

Buildings and improvements

 

 

126,726

 

 

 

134,946

 

Accumulated depreciation

 

 

(15,815

)

 

 

(14,908

)

 

 

 

130,665

 

 

 

145,444

 

Construction in progress

 

 

-

 

 

 

629

 

Net investment in real estate

 

 

130,665

 

 

 

146,073

 

Real estate held for sale

 

 

-

 

 

 

8,692

 

Investment in unconsolidated entities

 

 

140,926

 

 

 

156,242

 

Cash and cash equivalents

 

 

12,720

 

 

 

48,088

 

Restricted cash

 

 

32,703

 

 

 

14,197

 

Tenant and other receivables, net

 

 

3,907

 

 

 

3,665

 

Lease intangible assets, net

 

 

-

 

 

 

171

 

Prepaid expenses, deferred expenses and other assets, net

 

 

12,739

 

 

 

16,651

 

Total assets (1)

 

$

333,660

 

 

$

393,779

 

 

 

 

 

 

 

 

LIABILITIES AND SHAREHOLDERS' EQUITY

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

Term loan facility, net

 

$

14,454

 

 

$

47,677

 

Revolving loan facility

 

 

15,000

 

 

 

-

 

Accounts payable, accrued expenses and other liabilities

 

 

9,254

 

 

 

13,302

 

Total liabilities (1)

 

 

38,708

 

 

 

60,979

 

 

 

 

 

 

 

 

Commitments and Contingencies (Note 9)

 

 

 

 

 

 

 

 

 

 

 

 

 

Shareholders' Equity

 

 

 

 

 

 

Class A common shares $0.01 par value; 100,000,000 shares authorized;
  56,324,607 shares issued and outstanding as of September 30, 2026 and
  December 31, 2025

 

 

562

 

 

 

562

 

Series A preferred shares $0.01 par value; 10,000,000 shares authorized;
   2,800,000 shares issued and outstanding as of September 30, 2026 and
   December 31, 2025; liquidation preference of $70,000

 

 

28

 

 

 

28

 

Additional paid-in capital

 

 

1,362,028

 

 

 

1,362,719

 

Accumulated deficit

 

 

(1,067,666

)

 

 

(1,031,893

)

Total shareholders' equity

 

 

294,952

 

 

 

331,416

 

Non-controlling interests

 

 

-

 

 

 

1,384

 

Total equity

 

 

294,952

 

 

 

332,800

 

Total liabilities and equity

 

$

333,660

 

 

$

393,779

 

(1) The Company's condensed consolidated balance sheets include assets and liabilities of consolidated variable interest entities ("VIEs"). See Note 2. As of September 30, 2026, the Company no longer holds any consolidated VIEs. The consolidated balance sheets, as of December 31, 2025, include the following amounts related to our consolidated VIEs: $8.7 million included in real estate held for sale, $9.9 thousand of cash, $9.5 thousand of tenant and other receivables and $74.5 thousand of accounts payable, accrued expenses and other liabilities.

 

 

 

5


 

Seritage Growth Properties

Consolidated Statements of OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

 

 

 

For the Three Months
Ended September 30,

 

 

For the Nine Months
Ended September 30,

 

 

 

2026

 

 

2025

 

 

2026

 

 

2025

 

REVENUE

 

 

 

 

 

 

 

 

 

 

 

 

Rental income

 

$

1,502

 

 

$

4,603

 

 

$

5,171

 

 

$

13,586

 

Management and other fee income

 

 

133

 

 

 

182

 

 

 

388

 

 

 

451

 

Total revenue

 

 

1,635

 

 

 

4,785

 

 

 

5,559

 

 

 

14,037

 

EXPENSES

 

 

 

 

 

 

 

 

 

 

 

 

Property operating

 

 

486

 

 

 

3,625

 

 

 

2,708

 

 

 

9,770

 

Real estate taxes

 

 

345

 

 

 

607

 

 

 

1,062

 

 

 

2,252

 

Depreciation and amortization

 

 

385

 

 

 

1,698

 

 

 

1,175

 

 

 

5,813

 

General and administrative

 

 

4,925

 

 

 

4,922

 

 

 

15,313

 

 

 

26,787

 

Total expenses

 

 

6,141

 

 

 

10,852

 

 

 

20,258

 

 

 

44,622

 

Gain on sale of real estate

 

 

1,207

 

 

 

-

 

 

 

1,242

 

 

 

8,903

 

Loss on sale of interests in unconsolidated
  entities

 

 

—

 

 

 

-

 

 

 

—

 

 

 

(1,417

)

Impairment of real estate assets

 

 

—

 

 

 

(800

)

 

 

(15,183

)

 

 

(18,800

)

Equity in income (loss) of unconsolidated
  entities

 

 

7,707

 

 

 

644

 

 

 

1,048

 

 

 

(6,528

)

Interest and other income (expense), net

 

 

897

 

 

 

(834

)

 

 

2,290

 

 

 

956

 

Interest expense

 

 

(1,268

)

 

 

(5,290

)

 

 

(7,107

)

 

 

(15,659

)

Loss on debt extinguishment

 

 

(77

)

 

 

-

 

 

 

(77

)

 

 

-

 

Income (loss) before income taxes

 

 

3,960

 

 

 

(12,347

)

 

 

(32,486

)

 

 

(63,130

)

Provision for income taxes

 

 

—

 

 

 

(75

)

 

 

—

 

 

 

—

 

Net income (loss)

 

 

3,960

 

 

 

(12,422

)

 

 

(32,486

)

 

 

(63,130

)

Preferred dividends

 

 

(1,225

)

 

 

(1,225

)

 

 

(3,675

)

 

 

(3,675

)

Net income (loss) attributable to Seritage common
  shareholders

 

$

2,735

 

 

$

(13,647

)

 

$

(36,161

)

 

$

(66,805

)

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss) per share attributable to Seritage
  Class A common shareholders - Basic

 

$

0.05

 

 

$

(0.24

)

 

$

(0.64

)

 

$

(1.19

)

Net income (loss) per share attributable to Seritage
  Class A common shareholders - Diluted

 

$

0.05

 

 

$

(0.24

)

 

$

(0.64

)

 

$

(1.19

)

Weighted-average Class A common shares
   outstanding - Basic

 

 

56,324

 

 

 

56,324

 

 

 

56,324

 

 

 

56,311

 

Weighted-average Class A common shares
   outstanding - Diluted

 

 

56,324

 

 

 

56,324

 

 

 

56,324

 

 

 

56,311

 

 

 

 

Properties sold during the nine months ended September 30, 2026:

 

 

 

 

 

 

 

Total

 

2026 Qtr

 

City

 

State

 

Full / Partial Sale

 

Built SF

 

Sold

 

Alexandria

 

VA

 

Partial Site

 

-

 

Q1

 

Riverside

 

CA

 

Full Site

 

-

 

Q2

 

Riverside

 

CA

 

Full Site

 

33

 

Q3

 

Alexandria

 

VA

 

Partial Site

 

-

 

Q3

 

 

6


Filing Exhibits & Attachments

2 documents

Keep reading